药物信息为CHEWABLE TABLETS AND SUSPENSIONMINTEZOL (Thiabendazole) (Merck & Co., Inc.): DESCRIPTION
- DESCRIPTION
- CLINICAL PHARMACOLOGY
- INDICATIONS AND USAGE
- CONTRAINDICATIONS
- WARNINGS
- ADVERSE REACTIONS
- OVERDOSAGE
- DOSAGE AND ADMINISTRATION
- HOW SUPPLIED
- Diseases/Conditions Related to CHEWABLE TABLETS AND SUSPENSIONMINTEZOL (Thiabendazole) (Merck & Co., Inc.)
- 外部链接相关的CHEWABLE TABLETS AND SUSPENSIONMINTEZOL (Thiabendazole) (Merck & Co., Inc.)
MINTEZOL Registered trademark of MERCK & CO., Inc. COPYRIGHT © MERCK & CO., Inc., 1983 All rights reserved (Thiabendazole) is an anthelmintic provided as 500 mg chewable tablets, and as a suspension, containing 500 mg thiabendazole per 5 mL. The suspension also contains sorbic acid 0.1% added as a preservative. Inactive ingredients in the tablets are acacia, calcium phosphate, flavors, lactose, magnesium stearate, mannitol, methylcellulose, and sodium saccharin. Inactive ingredients in the suspension are an antifoam agent, flavors, polysorbate, purified water, sorbitol solution, and tragacanth.
Thiabendazole is a white to off-white odorless powder with a molecular weight of 201.26, which is practically insoluble in water but readily soluble in dilute acid and alkali. Its chemical name is 2-(4-thiazolyl)-1H -benzimidazole. The empirical formula is C10H7N3S and the structural formula is:

- Drug Information Provided by National Library of Medicine (NLM).
